ARCHIVES

Complaints Are “Astonishingly Far From Facts,” But NCI May Be Leaving Good Science Unfunded

This article is from The Cancer Letter archive.

Vol. 03 No. 17 | April 29, 1977

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

In Brief: Cancer Panel To Meet Aug.29; RFP On Impact Of Planning Cancelled As Being “Premature“

August 15, 1980

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

In Brief: Levine Leaves NIH For Pittsburgh; Fischbach Leaves Harvard For NIH; NCI Researcher Dies

June 12, 1998

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001